Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Cutia Therapeutics ( (HK:2487) ) is now available.
Cutia Therapeutics has announced that its board of directors will hold a meeting on March 24, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend payment and address other business matters, which could impact the company’s financial strategy and shareholder returns.
More about Cutia Therapeutics
Cutia Therapeutics is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on developing therapeutic solutions and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -14.83%
Average Trading Volume: 12,099,632
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$1.93B
Learn more about 2487 stock on TipRanks’ Stock Analysis page.